Home › Therapeutic areas › Oncology › Glioblastoma
Glioblastoma (15 companies)
Companies with an active program in Glioblastoma.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| DRTS | Alpha Tau Medical | Oncology | 1 | Phase 2 | 6 |
| CLRB | Cellectar Biosciences | Oncology | 1 | Phase 2 | 6 |
| CMPX | Compass Therapeutics | Oncology | 1 | Phase 2 | 15 |
| FBIO | Fortress Biotech | DermatologyHematology+2 Rare | 1 | Approved | 12 |
| IBRX | ImmunityBio | Infectious DiseaseOncology | 2 | Approved | 16 |
| INAB | IN8bio | ImmunologyOncology | 2 | Phase 2 | 6 |
| INBX | Inhibrx Biosciences | Oncology | 1 | NDA Submitted | 6 |
| KAPA | Kairos Pharma | Oncology | 1 | Phase 2 | 13 |
| KZIA | Kazia Therapeutics | Oncology Rare | 2 | Phase 2 | 10 |
| MAIA | MAIA Biotechnology | Oncology | 1 | Phase 3 | 7 |
| MDNAF | Medicenna Therapeutics | Oncology | 1 | Phase 2 | 9 |
| MBRX | Moleculin Biotech | Oncology | 3 | Phase 2 | 10 |
| NVCT | Nuvectis Pharma | HematologyOncology+1 Rare | 1 | Phase 3 | 8 |
| PYPD | PolyPid | Infectious DiseaseOncology | 1 | NDA Submitted | 2 |
| TNGX | Tango Therapeutics | Oncology | 1 | Phase 1 | 4 |
No companies match.